{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:43:57Z","timestamp":1792637037005,"version":"4.5.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>A comprehensive, stable, and efficient high-performance liquid chromatography\u2013tandem mass spectrometry method was developed for rapidly analyzing 14 antidepressants and 13 antipsychotics in human plasma for routine clinical therapeutic drug monitoring.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Simple protein precipitation was used for the pretreatment of plasma samples; dynamic multiple reaction monitoring was used to avoid the loss of sensitivity caused by numerous ion transitions. In all, 80 ion transitions of 40 compounds were quantitatively determined in 6 minutes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The limit of detection for the 27 analytes was in the range of 0.1\u201330 ng\/mL, and all calibration lines prepared using blank plasma were linear with a correlation coefficient of r<jats:sup>2<\/jats:sup> \u2265 0.99. The method was accurate and precise with acceptable intraday and interday precisions (coefficients of variation, \u226420% for a lower limit of quantification and \u226415% for other quality control samples) and an accuracy of 85.51%\u2013114.77%. This analysis method has been completely validated and successfully used in routine clinical therapeutic drug monitoring for more than 9963 samples [including 488 samples having drug concentrations above the laboratory alert level (supra\u2013alert-level samples)] at Xiamen Xianyue Hospital.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>This dynamic method is comprehensive (includes most antidepressants and antipsychotics listed in China), reliable (stably used for almost 2 years), and efficient (convenient sample processing and short run time) and provides a large amount of meaningful data for optimized pharmacotherapy. Our experimental data from the plasma concentrations of supra\u2013alert-level samples could serve as a reference for the interpretation of the pharmacokinetics of patients with a high risk of toxicity or loss of tolerability.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ftd.0000000000000839","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T22:32:39Z","timestamp":1606257159000},"page":"577-588","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["Rapid Simultaneous Determination of 14 Antidepressants and 13 Antipsychotics in Human Plasma by Using High-Performance Liquid Chromatography\u2013Tandem Mass Spectrometry With Dynamic Multiple Reaction Monitoring and Its Application to Therapeutic Drug Monitoring"],"prefix":"10.1097","volume":"43","author":[{"given":"Haiyan","family":"Lyu","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Xiamen Xianyue Hospital ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Xiamen Xianyue Hospital ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangzhen","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Xiamen Xianyue Hospital ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Fujian Provincial Key Laboratory of Innovative Drug Target Research and State Key Laboratory of Cell Stress Biology, School of Pharmaceutical Sciences, Xiamen University ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunling","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Xiamen Xianyue Hospital ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Zhongshan Hospital Xiamen University, Xiamen ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Xiamen Xianyue Hospital ;"},{"name":"Fujian Provincial Key Laboratory of Neurodegenerative Disease and Aging Research, Institute of Neuroscience, School of Medicine, Xiamen University, Xiamen, Fujian ; and"},{"name":"Mental Health Teaching and Research Section, School of Clinical Medicine, Fujian Medical University, Fuzhou, Fujian, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caisheng","family":"Wu","sequence":"additional","affiliation":[{"name":"Fujian Provincial Key Laboratory of Innovative Drug Target Research and State Key Laboratory of Cell Stress Biology, School of Pharmaceutical Sciences, Xiamen University ;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250603","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00007691-200502000-00004","article-title":"Cost-effectiveness of therapeutic drug monitoring: a systematic review","volume":"27","author":"Touw","year":"2005","journal-title":"Ther Drug Monit."},{"key":"R2-20250603","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00228-007-0430-1","article-title":"Clinical utility of drug measurement and pharmacokinetics: therapeutic drug monitoring in psychiatry","volume":"64","author":"Hiemke","year":"2008","journal-title":"Eur J Clin Pharmacol."},{"key":"R3-20250603","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/FTD.0000000000000041","article-title":"Psychiatrists' perspectives on antipsychotic dose and the role of plasma concentration therapeutic drug monitoring","volume":"36","author":"Best-Shaw","year":"2014","journal-title":"Ther Drug Monit."},{"key":"R4-20250603","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/FTD.0000000000000197","article-title":"Simple and accurate quantitative analysis of 16 antipsychotics and antidepressants in human plasma by ultrafast high-performance liquid chromatography\/tandem mass spectrometry","volume":"37","author":"Wang","year":"2015","journal-title":"Ther Drug Monit."},{"key":"R5-20250603","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jchromb.2006.05.031","article-title":"Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: a multi-level, single-sample approach","volume":"843","author":"Kirchherr","year":"2006","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"key":"R6-20250603","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jchromb.2012.09.009","article-title":"Liquid chromatography-tandem mass spectrometry method for determination of five antidepressants and four atypical antipsychotics and their main metabolites in human serum","volume":"907","author":"Urinovska","year":"2012","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"key":"R7-20250603","doi-asserted-by":"crossref","first-page":"39","DOI":"10.5507\/bp.2015.065","article-title":"Quantification of selected antidepressants and antipsychotics in clinical samples using chromatographic methods combined with mass spectrometry: a review (2006\u20132015)","volume":"160","author":"Sistik","year":"2016","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub."},{"key":"R8-20250603","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.chroma.2012.08.087","article-title":"Challenges in the development of bioanalytical liquid chromatography-mass spectrometry method with emphasis on fast analysis","volume":"1292","author":"Novakova","year":"2013","journal-title":"J Chromatogr A."},{"key":"R9-20250603","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jchromb.2010.11.024","article-title":"Quantification of antidepressants and antipsychotics in human serum by precipitation and ultra high pressure liquid chromatography-tandem mass spectrometry","volume":"879","author":"Hasselstrom","year":"2011","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"key":"R10-20250603","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jchromb.2015.04.040","article-title":"Analysis of drugs in plasma samples from schizophrenic patients by column-switching liquid chromatography-tandem mass spectrometry with organic-inorganic hybrid cyanopropyl monolithic column","volume":"993-994","author":"Domingues","year":"2015","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"key":"R11-20250603","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1570-0232(03)00393-3","article-title":"Analysis of eighteen antidepressants, four atypical antipsychotics and active metabolites in serum by liquid chromatography: a simple tool for therapeutic drug monitoring","volume":"794","author":"Frahnert","year":"2003","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"key":"R12-20250603","first-page":"28","article-title":"Determination of drugs in plasma samples by high-performance liquid chromatography-tandem mass spectrometry for therapeutic drug monitoring of schizophrenic patients","volume":"40","author":"Domingues","year":"2016","journal-title":"J Anal Toxicol."},{"key":"R13-20250603","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cca.2013.11.024","article-title":"High throughput identification and quantification of 16 antipsychotics and 8 major metabolites in serum using ultra-high performance liquid chromatography-tandem mass spectrometry","volume":"429","author":"Patteet","year":"2014","journal-title":"Clin Chim Acta."},{"key":"R14-20250603","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jchromb.2018.05.026","article-title":"Simultaneous analysis of olanzapine, fluoxetine, and norfluoxetine in human plasma using liquid chromatography-mass spectrometry and its application to a pharmacokinetic study","volume":"1092","author":"Ni","year":"2018","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"key":"R15-20250603","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0378-4347(00)00332-7","article-title":"Determination of nortriptyline in human serum by fully automated solid-phase extraction and on-line high-performance liquid chromatography in the presence of antipsychotic drugs","volume":"746","author":"Olesen","year":"2000","journal-title":"J Chromatogr B Biomed Sci Appl."},{"key":"R16-20250603","doi-asserted-by":"crossref","first-page":"e3928","DOI":"10.1002\/bmc.3928","article-title":"Development of a UPLC-MS\/MS method for routine therapeutic drug monitoring of aripiprazole, amisulpride, olanzapine, paliperidone and ziprasidone with a discussion of their therapeutic reference ranges for Chinese patients","volume":"31","author":"Wang","year":"2017","journal-title":"Biomed Chromatogr."},{"key":"R17-20250603","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1055\/s-0037-1600991","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry."},{"key":"R19-20250603","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/FTD.0000000000000585","article-title":"A compilation of serum concentrations of 12 antipsychotic drugs in a therapeutic drug monitoring setting","volume":"41","author":"Jonsson","year":"2019","journal-title":"Ther Drug Monit."},{"key":"R20-20250603","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/bcp.14246","article-title":"A systematic review and combined meta-analysis of concentration of oral amisulpride","volume":"86","author":"Li","year":"2020","journal-title":"Br J Clin Pharmacol."},{"key":"R21-20250603","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/FTD.0b013e3181dad1fb","article-title":"Plasma clozapine, norclozapine, and the clozapine:norclozapine ratio in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 1993\u20132007","volume":"32","author":"Couchman","year":"2010","journal-title":"Ther Drug Monit."},{"key":"R22-20250603","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/acps.12794","article-title":"Effects of age and gender on the serum levels of clozapine, olanzapine, risperidone, and quetiapine","volume":"136","author":"Castberg","year":"2017","journal-title":"Acta Psychiatr Scand."},{"key":"R23-20250603","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/jat\/31.5.254","article-title":"Reference concentrations of antidepressants. A compilation of postmortem and therapeutic levels","volume":"31","author":"Reis","year":"2007","journal-title":"J Anal Toxicol."},{"key":"R24-20250603","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.chroma.2014.12.084","article-title":"Comparison of conventional liquid chromatography-tandem mass spectrometry versus microflow liquid chromatography-tandem mass spectrometry within the framework of full method validation for simultaneous quantification of 40 antidepressants and neuroleptics in whole blood","volume":"1381","author":"Steuer","year":"2015","journal-title":"J Chromatogr A."},{"key":"R25-20250603","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jpba.2012.04.016","article-title":"A reliable and rapid tool for plasma quantification of 18 psychotropic drugs by ESI tandem mass spectrometry","volume":"67-68","author":"Vecchione","year":"2012","journal-title":"J Pharm Biomed Anal."},{"key":"R26-20250603","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/978-1-4939-3252-8_6","article-title":"Quantitation of haloperidol, fluphenazine, perphenazine, and thiothixene in serum or plasma using liquid chromatography-tandem mass spectrometry (LC-MS\/MS)","volume":"1383","author":"Slawson","year":"2016","journal-title":"Methods Mol Biol."},{"key":"R27-20250603","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cca.2013.04.014","article-title":"Simultaneous UPLC-MS\/MS assay for the detection of the traditional antipsychotics haloperidol, fluphenazine, perphenazine, and thiothixene in serum and plasma","volume":"423","author":"Juenke","year":"2013","journal-title":"Clin Chim Acta"},{"key":"R28-20250603","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jpba.2013.07.041","article-title":"Quantification of typical antipsychotics in human plasma by ultra-high performance liquid chromatography tandem mass spectrometry for therapeutic drug monitoring","volume":"88","author":"Gradinaru","year":"2014","journal-title":"J Pharm Biomed Anal."},{"key":"R29-20250603","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/FTD.0b013e3182892d11","article-title":"Monitoring haloperidol exposure in body fluids and hair of children by liquid chromatography-high-resolution mass spectrometry","volume":"35","author":"Favretto","year":"2013","journal-title":"Ther Drug Monit."},{"key":"R30-20250603","first-page":"129","article-title":"Genotyping and phenotyping of CYP2D6 and CYP3A isoenzymes in patients with alcohol use disorder: correlation with haloperidol plasma concentration","volume":"32","author":"Sychev","year":"2017","journal-title":"Drug Metab Pers Ther."},{"key":"R31-20250603","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00216-011-5187-9","article-title":"Ultra high performance liquid chromatographic-tandem mass spectrometric multi-analyte procedure for target screening and quantification in human blood plasma: validation and application for 31 neuroleptics, 28 benzodiazepines, and Z-drugs","volume":"401","author":"Remane","year":"2011","journal-title":"Anal Bioanal Chem."},{"key":"R32-20250603","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/jms.1783","article-title":"Identification and quantification of 30 antipsychotics in blood using LC-MS\/MS","volume":"45","author":"Saar","year":"2010","journal-title":"J Mass Spectrom."},{"key":"R33-20250603","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/14740338.2020.1698545","article-title":"The clozapine to norclozapine ratio: a narrative review of the clinical utility to minimize metabolic risk and enhance clozapine efficacy","volume":"19","author":"Costa-Dookhan","year":"2020","journal-title":"Expert Opin Drug Saf."},{"key":"R34-20250603","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/FTD.0b013e3182708ec5.","article-title":"Therapeutic drug monitoring of common antipsychotics","volume":"34","author":"Patteet","year":"2012","journal-title":"Ther Drug Monit."},{"key":"R35-20250603","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/17512433.2019.1577134","article-title":"A comprehensive review of swallowing difficulties and dysphagia associated with antipsychotics in adults","volume":"12","author":"Cicala","year":"2019","journal-title":"Expert Rev Clin Pharmacol."},{"key":"R36-20250603","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1177\/0269881118795333","article-title":"Antipsychotic drug use and pneumonia: systematic review and meta-analysis","volume":"32","author":"Dzahini","year":"2018","journal-title":"J Psychopharmacol."},{"key":"R37-20250603","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/pds.3804","article-title":"Antipsychotic drug exposure and risk of pneumonia: a systematic review and meta-analysis of observational studies","volume":"24","author":"Nose","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"R38-20250603","doi-asserted-by":"crossref","first-page":"e100183","DOI":"10.1136\/gpsych-2019-100183","article-title":"Clozapine is strongly associated with the risk of pneumonia and inflammation","volume":"33","author":"de Leon","year":"2020","journal-title":"Gen Psychiatr."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000839","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:20:46Z","timestamp":1748971246000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000839","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"2020-08-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}